Home
>
National Drug Code (NDC)
>
Lisinopril and hydrochlorothiazide
Lisinopril and hydrochlorothiazide - 53808-0452-1 - (LISINOPRIL AND HYDROCHLOROTHIAZIDE)
Drug Information of Lisinopril and hydrochlorothiazide
| Product NDC: | 53808-0452 |
| Proprietary Name: | Lisinopril and hydrochlorothiazide |
| Non Proprietary Name: | LISINOPRIL AND HYDROCHLOROTHIAZIDE |
| Active Ingredient(s): | 12.5; 5 mg/1; mg/1 & nbsp; LISINOPRIL AND HYDROCHLOROTHIAZIDE |
| Administration Route(s): | ORAL |
| Dosage Form(s): | TABLET |
| Coding System: | National Drug Codes(NDC) |
Labeler Information of Lisinopril and hydrochlorothiazide
| Product NDC: | 53808-0452 |
| Labeler Name: | State of Florida DOH Central Pharmacy |
| Product Type: | HUMAN PRESCRIPTION DRUG |
| FDA Application Number: | ANDA078402 |
| Marketing Category: | ANDA |
| Start Marketing Date: | 20090701 |
Package Information of Lisinopril and hydrochlorothiazide
| Package NDC: | 53808-0452-1 |
| Package Description: | 30 TABLET in 1 BLISTER PACK (53808-0452-1) |
NDC Information of Lisinopril and hydrochlorothiazide
| NDC Code | 53808-0452-1 |
| Proprietary Name | Lisinopril and hydrochlorothiazide |
| Package Description | 30 TABLET in 1 BLISTER PACK (53808-0452-1) |
| Product NDC | 53808-0452 |
| Product Type Name | HUMAN PRESCRIPTION DRUG |
| Non Proprietary Name | LISINOPRIL AND HYDROCHLOROTHIAZIDE |
| Dosage Form Name | TABLET |
| Route Name | ORAL |
| Start Marketing Date | 20090701 |
| Marketing Category Name | ANDA |
| Labeler Name | State of Florida DOH Central Pharmacy |
| Substance Name | HYDROCHLOROTHIAZIDE; LISINOPRIL |
| Strength Number | 12.5; 5 |
| Strength Unit | mg/1; mg/1 |
| Pharmaceutical Classes | Increased Diuresis [PE],Thiazide Diuretic [EPC],Thiazides [Chemical/Ingredient] |
